# Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA)

> **NCT01352858** · PHASE1 · COMPLETED · sponsor: **Newcastle University** · enrollment: 14 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** TolDC
- **DRUG:** Arthroscopy & saline irrigation alone

## Key facts

- **NCT ID:** NCT01352858
- **Lead sponsor:** Newcastle University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352858, "Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01352858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*